Carbon Disclosure Project publishes new climate ranking: Bayer an international leader in its sector in climate protection

Leverkusen, October 25, 2016- The Carbon Disclosure Project (CDP) has once again rated Bayer as one of the leading international companies in the pharmaceuticals sector in regard to climate protection. In conducting its comparative study of the world's 500 largest stock-market-listed companies, the CDP focused on their strategic approach to the challenges of climate change. Bayer was awarded CDP Leadership Status with an 'A' rating, the highest given.

'We are delighted to be recognized by the CDP,' said Dr. Hartmut Klusik, the Bayer Board of Management member responsible for Human Resources, Technology and Sustainability. 'Climate protection and coping with the consequences of climate change remain a permanent challenge for society as a whole. We are taking on this challenge at Bayer and will continue to make important contributions.'

Bayer's commitment combines measures for reducing greenhouse gas emissions with the development of resource-conserving products and solutions. The Group is pursuing its target of reducing specific greenhouse gas emissions by 15 percent by the year 2020 compared with 2012 levels, for example.

Part of the Group's strategy is to cultivate new business models that take advantage of opportunities offered by digitalization. The company wants this approach to also tap into even more potential for reducing greenhouse gas emissions - whether in production, distribution or application of its products and services.

In agriculture, for example, Bayer is going to place even greater emphasis on 'digital farming' in the future, by providing detailed, comprehensive information on growing conditions that will help farmers to optimize their use of resources.

In addition, Bayer has been providing in-depth, transparent coverage of climate-related aspects in its Integrated Annual Report for years.

The CDP is a non-profit organization that serves the needs of institutional investors by annually gathering and evaluating climate data submitted by the world's 500 largest stock-market-listed companies. According to the CDP, this information is currently used for investment decision-making by more than 800 investors managing fund assets of approximately USD 100 trillion.

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go towww.bayer.com.

For more information, visitwww.cdp.net

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website atwww.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.